FRONTOTEMPORAL LOBAR DEGENERATION WITH TDP43 INCLUSIONS, TARDBP-RELATED: genes and variants
Explore variant evidence for FRONTOTEMPORAL LOBAR DEGENERATION WITH TDP43 INCLUSIONS, TARDBP-RELATED across 1 analyzed protein (TARDBP). Linked ClinVar records include 8 pathogenic or likely pathogenic variants, 3 variants of uncertain significance and 4 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Counts refer to the selected disease label.
Data updated 2026-10-21. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to FRONTOTEMPORAL LOBAR DEGENERATION WITH TDP43 INCLUSIONS, TARDBP-RELATED
TARDBP: TAR DNA-binding protein 43
TDP-43 is an RNA-binding protein that regulates RNA processing, splicing, stability, and transport. Its normal activity supports neuronal and muscle cells, while abnormal TDP-43 accumulation is closely associated with amyotrophic lateral sclerosis and frontotemporal degeneration.
8 ClinVar pathogenic / likely pathogenic and 7 uncertain variants in TARDBP have source records linked to FRONTOTEMPORAL LOBAR DEGENERATION WITH TDP43 INCLUSIONS, TARDBP-RELATED. Association strength is not clinical gene validity.
Where FRONTOTEMPORAL LOBAR DEGENERATION WITH TDP43 INCLUSIONS, TARDBP-RELATED variants cluster
- TARDBP Interaction with UBQLN2 (positions 216–414): 7 of 7 ClinVar pathogenic / likely pathogenic variants, 2.1× more than its size predicts (a length-based count, not a validated hotspot).
ClinVar pathogenic and likely pathogenic variants linked to FRONTOTEMPORAL LOBAR DEGENERATION WITH TDP43 INCLUSIONS, TARDBP-RELATED
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| TARDBP G294A | 294 | Interaction with UBQLN2 | Pathogenic / likely pathogenic (★★) |
| TARDBP G294V | 294 | Interaction with UBQLN2 | Pathogenic / likely pathogenic (★★) |
| TARDBP M337V | 337 | Interaction with UBQLN2 | Pathogenic / likely pathogenic (★★) |
| TARDBP A382T | 382 | Interaction with UBQLN2 | Pathogenic / likely pathogenic (★★) |
| TARDBP G298S | 298 | Interaction with UBQLN2 | Pathogenic / likely pathogenic (★★) |
| TARDBP A315T | 315 | Interaction with UBQLN2 | Pathogenic / likely pathogenic (★★) |
| TARDBP G348C | 348 | Interaction with UBQLN2 | Pathogenic / likely pathogenic (★★) |
| TARDBP G295S | 295 | Interaction with UBQLN2 | Pathogenic / likely pathogenic (★) |
Uncertain variants prioritized for review in FRONTOTEMPORAL LOBAR DEGENERATION WITH TDP43 INCLUSIONS, TARDBP-RELATED
| Variant | Position | Protein part | Clinical label | Evidence |
|---|---|---|---|---|
| TARDBP G295R | 295 | Interaction with UBQLN2 | Conflicting reports (★) | +6: 4 other pathogenic changes within 3 positions; G295S at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 0.78 |
Same protein, different disease
- Amyotrophic lateral sclerosis also has ClinVar records linked to TARDBP variants; they fall mostly in different places as the FRONTOTEMPORAL LOBAR DEGENERATION WITH TDP43 INCLUSIONS, TARDBP-RELATED variants (12 pathogenic / likely pathogenic).
Diseases related to FRONTOTEMPORAL LOBAR DEGENERATION WITH TDP43 INCLUSIONS, TARDBP-RELATED
- Amyotrophic lateral sclerosis, also linked to TARDBP
- Motor neuron disease, also linked to TARDBP
Frequently asked questions
Which genes have records linked to FRONTOTEMPORAL LOBAR DEGENERATION WITH TDP43 INCLUSIONS, TARDBP-RELATED?
This view contains 1 analyzed proteins: TARDBP. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 8 pathogenic or likely pathogenic variants, 3 variants of uncertain significance and 4 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 1 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 15 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center